Literature DB >> 8272415

Physicochemical characterization of high- and low-melting phenylephrine oxazolidines.

Y Qiu1, R D Schoenwald, J K Guillory.   

Abstract

Phenylephrine oxazolidine is a new prodrug of phenylephrine developed for improving ocular absorption and reducing systemic side effects. In the present study, high- and low-melting phenylephrine oxazolidines (HMP and LMP) were characterized in terms of their stereochemistry and crystal properties. It was found that the molecular configuration of the prodrug in the crystals of either HMP or LMP is identical (5R/2R). The two crystals were shown to have the same IR spectra and X-ray diffraction patterns but different crystal habits, thermal properties, solubilities and intrinsic dissolution rates. Single crystal X-ray structure analysis indicates that crystals of both HMP and LMP are orthorhombic and belong to the P2(1)2(1)2(1) space group with four molecules in a unit cell (a = 20.697 A, b = 7.065 A, and c = 9.304 A). The molecules in the crystal are held together by an intermolecular hydrogen bonding interaction between N(3) and O(13). The different physical properties observed for LMP result from crystal imperfections caused by the presence of trace amounts (often at levels < 0.5%) of an unidentified, structurally related synthetic impurity which can be dispersed in the prodrug. It was observed that both HMP and LMP can sustain thermal and mechanical treatment in the solid state. However, LMP was partially converted to HMP when suspended in certain solvents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272415     DOI: 10.1023/a:1018939728993

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Physical characterization of solid iopanoic acid forms.

Authors:  W C Stagner; J K Guillory
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

2.  Phenylephrine prodrug. Report of clinical trials.

Authors:  M J Miller-Meeks; T A Farrell; P M Munden; J C Folk; C Rao; R D Schoenwald
Journal:  Ophthalmology       Date:  1991-02       Impact factor: 12.079

3.  In vivo comparison of phenylephrine and phenylephrine oxazolidine instilled in the monkey eye.

Authors:  R D Schoenwald; J C Folk; V Kumar; J G Piper
Journal:  J Ocul Pharmacol       Date:  1987

4.  Improving the ocular absorption of phenylephrine.

Authors:  D S Chien; R D Schoenwald
Journal:  Biopharm Drug Dispos       Date:  1986 Sep-Oct       Impact factor: 1.627

5.  Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

Authors:  D S Chien; R D Schoenwald
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

  5 in total
  1 in total

Review 1.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.